Overexpression of miR-4433 by suberoylanilide hydroxamic acid suppresses growth of CML cells and induces apoptosis through targeting Bcr-Abl
Conclusion: miR-4433 was identified as a microRNA targeting Bcr-Abl, which may be subject to epigenetic regulation of SAHA, a histone deacetylase inhibitor that has been approved by the US FDA for the treatment of cutaneous T-cell lymphoma. The findings of this study provide a molecular basis from another angle for the use of SAHA in the treatment of CML.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Haiyan Wu, Jingyi Yin, Zhengdong Ai, Guiming Li, Yan Li, Li Chen Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Cutaneous T cell lymphoma | Lymphoma | Study | T-cell Lymphoma